Buy Lucius Adagrasib online
Buy Lucius Adagrasib online
Buy Lucius Adagrasib online
Buy Lucius Adagrasib online

Buy Lucius Adagrasib online

MYR 2,600.00

400+ terjual
Harga Promosi

Farmasi fizikal Hong Kong dengan jaminan produk tulen 100%

Sorotan Produk

In 2022, adagrasib, a prescription medicine targeting KRAS G12C, received accelerated FDA approval in the United States. Use only as directed by a physician.

Jaminan Perkhidmatan

Penghantaran Rentas SempadanFarmasi BerlesenDisemak Ahli FarmasiJaminan Ketulenan

Spesifikasi

Spesifikasi
200mg*90 tablets
Pengilang
Lucius Pharmaceuticals
Penghantaran
Hong Kong

10000 in stock

Categories: , Tags: , , Brand:

Maklumat Produk

Nama Inggeris
Adagrasib
Nama Generik
Adagrasib

Spesifikasi

Spesifikasi
200mg*90 tablets
Pengilang
Lucius Pharmaceuticals
Penghantaran
Hong Kong

Butiran Penuh

Indikasi

Indicated for adults with previously treated KRAS G12C-positive advanced non-small cell lung cancer or colorectal cancer.

Mekanisme Tindakan

Adagrasib Mekanisme Tindakan Mekanisme Tindakan ，

Dos dan Cara Penggunaan

2 • (NSCLC) (CRC) Recommended dosage: 600 mg， (2.2) • ， (2.2) 2.1 KRAS G12C ， NSCLC KRAZATI [ (14.1)] ， KRAS G12C ， CRC KRAZATI [ (14.2)] FDA KRAS G12C ， 2.2 KRAZATI 600 mg，

Langkah Berjaga-jaga

5 Langkah Berjaga-jaga • ， ， (2.3, 5.1) • QTc KRAZATI QTc QT ， ， ，

Package Insert

Ingredients

11 Description Adagrasib KRAS G12C ， RAS GTPase C₃₂H₃₅ClFN₇O₂， 604.1 g/mol {(2S)-4-[7-(8- -1- )-2-{[(2S)-1- -2- ]- }-5,6,7,8- [3,4-d] -4- ]-1-(2- -2- ) -2- } Adagrasib Adagrasib pH 1.2 7.4 ，adagrasib > 262 mg/mL < 0.010 mg/mL

Indications

Indicated for adults with previously treated KRAS G12C-positive advanced non-small cell lung cancer or colorectal cancer.

Dos dan Cara Penggunaan

2 • (NSCLC) (CRC) Recommended dosage: 600 mg， (2.2) • ， (2.2) 2.1 KRAS G12C ， NSCLC KRAZATI [ (14.1)] ， KRAS G12C ， CRC KRAZATI [ (14.2)] FDA KRAS G12C ， 2.2 KRAZATI 600 mg，

Precautions

5 Langkah Berjaga-jaga • ， ， (2.3, 5.1) • QTc KRAZATI QTc QT ， ， ，

Clinical Pharmacology

12 12.1 Mekanisme Tindakan Adagrasib KRAS G12C ， KRAS G12C ， KRAS ， ， KRAS Adagrasib KRAS G12C ， KRAS G12C ， Adagrasib ，Adagrasib KRAS G12C CRC 12.2 Adagrasib - Adagrasib QTc

Clinical Studies

14 14.1 KRYSTAL-1 NCT03785249 adagrasib KRYSTAL-1 KRAS G12C ， ， ECOG 0 1， RECIST v1.1 KRAS G12C adagrasib 600 mg， 6

Ulasan Produk (13)

Filter: All Reviews
4.8★★★★★
+o***e· 3 weeks ago
★★★★
+t***3· 1 months ago
Pembelian Disahkan
★★★★★

Penerangan produk

Indikasi

Indicated for adults with previously treated KRAS G12C-positive advanced non-small cell lung cancer or colorectal cancer.

Mekanisme Tindakan

Adagrasib Mekanisme Tindakan Mekanisme Tindakan ，

Dos dan Cara Penggunaan

2 • (NSCLC) (CRC) Recommended dosage: 600 mg， (2.2) • ， (2.2) 2.1 KRAS G12C ， NSCLC KRAZATI [ (14.1)] ， KRAS G12C ， CRC KRAZATI [ (14.2)] FDA KRAS G12C ， 2.2 KRAZATI 600 mg，

Langkah Berjaga-jaga

5 Langkah Berjaga-jaga • ， ， (2.3, 5.1) • QTc KRAZATI QTc QT ， ， ，